Tratamiento farmacológico de la hiperplasia prostática benigna. Revisión de la bibliografía

Thumbnail
View/Open
Date
2018

Authors

López Ramos, Hugo Enrique
Medina Rico, Mauricio Alejandro
Bastidas Rosas, Danielle
Lara B.

Corporate Author(s)

Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Cirugía y Especialidades. Urología
Pontificia Universidad Javeriana. Facultad de Medicina. Hospital Universitario San Ignacio

Type

Artículos

ISSN

0035-0001

COAR

Artículo de revisión
Share this record
Gestores bibliográficos
Metadata
Show full item record
Documentos PDF

Resumen

Benign prostatic hyperplasia affects 50% of the population and is more frequent in the seventh and eighth decades of life. There are currently different treatments for benign prostatic hyperplasia and pharmacologic management is considered first-line trea

Keywords

Alfuzosin
Doxazosin
Dutasteride
Fesoterodine
Finasteride
Naftopidil
Sabal Extract
Sildenafil
Silodosin
Tadalafil
Tamsulosin
Article
Clinical Effectiveness
Drug Efficacy
Human
Palliative Therapy
Patient Preference
Phytotherapy
Practice Gu

Link to the resource

https://revistamexicanadeurologia.org.mx/index.php/rmu/article/view/96

DOI

https://doi.org/10.48193/revistamexicanadeurologa.v78i4.96

URI

http://hdl.handle.net/10554/60043

Source

Revista Mexicana de Urologia; Volumen 78 Número 4 , Páginas 321 - 334 (2018)
Estadísticas Google Analytics
Collections
Atribución-NoComercial 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución-NoComercial 4.0 Internacional